UBS Group’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$258K Buy
830,645
+325,538
+64% +$101K ﹤0.01% 5322
2025
Q1
$247K Buy
505,107
+63,338
+14% +$31K ﹤0.01% 5162
2024
Q4
$378K Buy
441,769
+158,084
+56% +$135K ﹤0.01% 4875
2024
Q3
$2.41M Buy
283,685
+111,622
+65% +$949K ﹤0.01% 2887
2024
Q2
$804K Buy
172,063
+19,303
+13% +$90.1K ﹤0.01% 3578
2024
Q1
$1.04M Buy
152,760
+32,553
+27% +$221K ﹤0.01% 3523
2023
Q4
$403K Buy
120,207
+11,826
+11% +$39.6K ﹤0.01% 4125
2023
Q3
$270K Buy
108,381
+1,738
+2% +$4.33K ﹤0.01% 4059
2023
Q2
$137K Buy
106,643
+32,942
+45% +$42.2K ﹤0.01% 4723
2023
Q1
$59.8K Buy
73,701
+62,333
+548% +$50.6K ﹤0.01% 5240
2022
Q4
$8.64K Sell
11,368
-15,781
-58% -$12K ﹤0.01% 7556
2022
Q3
$26K Buy
27,149
+1,286
+5% +$1.23K ﹤0.01% 5948
2022
Q2
$24K Buy
25,863
+3,850
+17% +$3.57K ﹤0.01% 5607
2022
Q1
$47K Sell
22,013
-52,408
-70% -$112K ﹤0.01% 5531
2021
Q4
$666K Buy
74,421
+53,211
+251% +$476K ﹤0.01% 3764
2021
Q3
$352K Sell
21,210
-1,075
-5% -$17.8K ﹤0.01% 3932
2021
Q2
$463K Sell
22,285
-4,355
-16% -$90.5K ﹤0.01% 3801
2021
Q1
$500K Buy
26,640
+2,359
+10% +$44.3K ﹤0.01% 3927
2020
Q4
$535K Sell
24,281
-78,409
-76% -$1.73M ﹤0.01% 3633
2020
Q3
$2.13M Buy
102,690
+20,450
+25% +$425K ﹤0.01% 2354
2020
Q2
$2.97M Buy
82,240
+77,205
+1,533% +$2.79M ﹤0.01% 1976
2020
Q1
$164K Sell
5,035
-5,190
-51% -$169K ﹤0.01% 4039
2019
Q4
$279K Buy
10,225
+6,482
+173% +$177K ﹤0.01% 4360
2019
Q3
$41K Buy
3,743
+1,599
+75% +$17.5K ﹤0.01% 5349
2019
Q2
$18K Buy
+2,144
New +$18K ﹤0.01% 5804